SAN LEANDRO, Calif.--(BUSINESS WIRE)-- The availability of, and demand for, at-home diagnostic products is on the rise – the market for point-of-care diagnostics is projected to reach $37 billion by the end of 2021. Consumers are seeking options to assess their own health through affordable, technologically advanced yet simple to use self-monitoring solutions. The first Food and Drug Administration-cleared home hearing assessment kit, called the iHEARtest™, has been introduced by iHear Medical, Inc. to give consumers control of their own hearing health.